Armstead, William M. Role of opioids in hypoxic pial artery dilation is stimulus duration dependent. Am. J. Physiol. 275 (Heart Circ. Physiol. 44): H861-H867, 1998.-Because methionine enkephalin contributes to and dynorphin opposes dilation during a 10-min hypoxic exposure, opioids modulate pial artery dilation to this stimulus. However, such modulation may be dependent on the duration of hypoxia. The present study was designed to characterize the modulation of hypoxic pial dilation by opioids as a function of stimulus duration in newborn pigs equipped with a closed cranial window. Hypoxic dilation was decremented in both moderate and severe groups (PO 2 Ϸ 35 and 25 mmHg, respectively) during 20-min and 40-min exposure periods compared with the response during 5 or 10 min of stimulation (24 Ϯ 1, 25 Ϯ 1, 18 Ϯ 1, and 14 Ϯ 1% for 5, 10, 20, and 40 min of moderate hypoxia; means Ϯ SE). Moderate and severe hypoxia had no effect on cerebral spinal fluid (CSF) methionine enkephalin or dynorphin concentration during a 5-min exposure period. During a 10-min exposure, however, both opioids were increased in CSF. During 20-and 40-min exposure periods, CSF dynorphin continued to increase, whereas methionine enkephalin steadily decreased (962 Ϯ 18, 952 Ϯ 21, 2,821 Ϯ 15, 2,000 Ϯ 81, and 1,726 Ϯ 58 pg/ml methionine enkephalin for control, 5, 10, 20, and 40 min of moderate hypoxia, respectively). The µ-opioid (methionine enkephalin) antagonist ␤-funaltrexamine had no influence on dilation during the 5-min exposure, decremented the 10-and 20-min exposures, but had no effect on 40-min exposure hypoxic dilation. Whereas the -opioid (dynorphin) antagonist norbinaltorphimine similarly had no effect on a 5-min exposure dilation, it, in contrast, potentiated 10-, 20-, and 40-min exposure hypoxic dilations (23 Ϯ 1 vs. 23 Ϯ 1, 24 Ϯ 1 vs. 32 Ϯ 1, 16 Ϯ 1 vs. 24 Ϯ 2, and 13 Ϯ 1 vs. 23 Ϯ 3% for 5, 10, 20, and 40-min hypoxic dilation before and after norbinaltorphimine). These data show that opioids do not modulate hypoxic pial dilation during short but do so during longer exposure periods. Moreover, hypoxic pial dilation is diminished during longer exposure periods. Decremented hypoxic pial dilation during longer exposure periods results, at least in part, from decreased release of methionine enkephalin and accentuated release of dynorphin. These data suggest that the relative role of opioids in hypoxic pial dilation changes with the stimulus duration. newborn; cerebral circulation Address for reprint requests: W. M. Armstead,
OPIOIDS CONTRIBUTE to the regulation of cerebral hemodynamics. Opioid receptor binding has been demonstrated on cerebral microvessels (13) . Enkephalin and dynorphin immunoreactivity, indicative of innervation, has been shown in large cerebral arteries of the pig and guinea pig, respectively (10, 19) . Furthermore, opioids have been detected in cerebrospinal fluid (CSF) (11) , and CSF opioid concentrations are in the vasoactive range under control conditions in the newborn pig (3, 4) .
Several mechanisms have been proposed to account for hypoxia-induced cerebrovasodilation, including adenosine, prostaglandins, and nitric oxide (NO) (1, 5, 12, 22, 24) . Additionally, it has been observed that hypoxia increases plasma methionine enkephalin in fetal sheep (9) and plasma ␤-endorphin in human newborns at delivery (8, 21) and in those infants with hypoxic-ischemic encephalopathy with ongoing hypoxia (15) . In the piglet, hypoxic pial artery dilation is associated with elevated cortical periarachnoid CSF methionine enkephalin and dynorphin concentration (1) . Because the µ-opioid (methionine enkephalin) (6) antagonist ␤-funaltrexamine attenuates whereas the -opioid (dynorphin) (6) antagonist norbinaltorphimine potentiates hypoxic pial artery dilation, it had been previously suggested that opioids modulate hypoxic pial artery dilation (1) .
The duration of the stimulus period could determine the relative contributions of different mechanisms to hypoxic pial artery dilation. Reasons for differences between our data indicating a role for NO in hypoxic pial dilation and those of Leffler et al. (7) , which do not, are uncertain but could relate to a more prolonged hypoxic exposure in our study (10 min) compared with that of Leffler et al. (5 min) . It is not inconceivable, therefore, that a more robust hypoxic exposure could activate mechanisms not recruited during a shorter stimulation period. Whereas opioids have been observed to modulate hypoxic pial dilation during a 10-min exposure period (1, 2) , the ability of such opioids to do so during shorter or longer exposure periods is uncertain.
The present study, therefore, was designed to characterize the modulation of hypoxic pial artery dilation by opioids as a function of stimulus duration.
METHODS
All experiments have been approved by the Institutional Animal Care and Use Committee. Seventy-two pigs (1-5 days old) of either sex were used in these experiments. They were first anesthetized with ketamine hydrochloride-acepromazine (33 mm/kg im). Anesthesia was maintained with ␣-chloralose (30-50 mg/kg initially, supplemented with 5 mg/kg iv). A catheter was inserted into the femoral artery to record blood pressure and to sample for blood gases and pH. Another catheter was placed in a femoral vein for injection of drugs. The trachea was cannulated, and the animals were ventilated with room air. The body temperature was maintained at 37-38°C with a heating pad.
For insertion of the cranial window, the scalp was removed and an opening was made in the skull over the parietal cortex. The dura was cut and retracted over the cut bone edge. The cranial window was placed in the hole and cemented in place with dental acrylic. The space under the window was filled with artificial CSF of the following composition (in mM): 3.0 KCl, 1.5 MgCl 2 , 1.5 CaCl 2 , 132 NaCl, 6.6 urea, 3.7 dextrose, and 24.6 NaHCO 3 (with pH 7.30-7.36, PCO 2 42-49 mmHg, and PO 2 40-50 mmHg).
Pial arterioles were observed with a dissecting microscope, a television camera mounted on the microscope, and a video monitor. Vascular diameter was measured with a video microscaler.
Protocol. Animals were divided into nine groups: 1) 5-and 10-min moderate and severe hypoxia time control (n ϭ 8), 2) 20-min moderate and severe hypoxia time control (n ϭ 8), 3) 40-min moderate and severe hypoxia time control (n ϭ 8), 4) 5-and 10-min moderate and severe hypoxia before and after ␤-funaltrexamine (n ϭ 8) 5) 20-min moderate and severe hypoxia before and after ␤-funaltrexamine (n ϭ 8) 6) 40 min moderate and severe hypoxia before and after ␤-funaltrexamine (n ϭ 8), 7) 5-and 10-min moderate and severe hypoxia before and after norbinaltorphimine (n ϭ 8), 8) 20-min moderate and severe hypoxia before and after norbinaltorphimine (n ϭ 8), and 9) 40-min moderate and severe hypoxia before and after norbinaltorphimine (n ϭ 8). Time control experiments were designed so that responses were obtained initially (defined as 1st in Tables 1 and 2) and then again 30 min later (defined as 2nd in Tables 1 and 2 ). Severity and durations of hypoxia were randomized within groups.
Hypoxia (5-, 10-, 20-, and 40-min duration) was produced by decreasing the inspired oxygen sufficiently to reduce and maintain arterial PO 2 (Pa O 2 ) at 35 Ϯ 3 mmHg (for moderate hypoxia) and at 25 Ϯ 3 mmHg (for severe hypoxia), while arterial PCO 2 (Pa CO 2 ) was maintained constant in the normocapnic range (33 Ϯ 3 mmHg). Changes in pial artery diameter (small artery 120-160 µm; arteriole 50-70 µm) were measured every minute during the last 5 min of each hypoxic exposure period. Two sizes of pial arteries were investigated to determine if regional vascular differences with respect to the modulation of hypoxic dilation by opioids could be observed. A sample of blood confirming the hypoxia was taken 3 min after the hypoxia began. Once the blood chemistry data confirmed that the desired level of hypoxia had been achieved, dilator responses were recorded. In longer hypoxic exposure animals, dilator responses were also recorded during the initial 10 min of exposure to confirm that these animals had responded appropriately to the stimulus. Therefore, differences observed at 20 or 40 min of hypoxic exposure would not be due to an initially aberrant response. Responses to hypoxia were separately obtained both before and after ␤-funaltrexamine (10 Ϫ8 M) or norbinaltorphimine (10 Ϫ6 M, Research Biochemicals, Natick, MA). For hypoxia experiments in the presence of ␤-funaltrexamine or norbinaltorphimine, these inhibitors were topically applied 10 min before induction of hypoxia, and the subsequent effects of the inhibitor on hypoxia-induced pial artery dilation were observed for the succeeding variable (5, 10, 20, or 40 min) exposure period. Appropriate aliquots of the vehicle for these agents (0.9% saline) were added to CSF infused under the window. This CSF vehicle had no effect on pial artery diameter.
Cortical periarachnoid CSF was collected 10 min after each hypoxic exposure period and therefore represents the amount of opioid released after a given stimulus period. Needles incorporated into the side of the cranial window allowed for the injection of CSF under the window and the runoff of excess CSF. For sample collection, 300 µl of CSF were collected from under the cranial window, which has a total volume of 500 µl, thereby minimizing dilution of the sample. The CSF (300 µl) was collected by slowly infusing artificial CSF into one side of the window and allowing the CSF under the window to drip freely into a collection tube on the opposite side.
Opioid analysis. The CSF samples collected were acidified with 1 N acetic acid to prevent protein degradation and stored at Ϫ20°C. RIA kits for methionine enkephalin and dynorphin are commercially available (IncStar, Stillwater, MN; Peninsula Laboratory, Belmont, CA). The RIA used simultaneous addition of the sample, anti-opioid antibody, and the 125 I derivative of the opioid. After an overnight incubation at 4°C, the free opioid was first separated from the opioid bound to the antibody by the addition of saturated ammonium sulfate (Tables 1 and 2 ). Whereas 5 min of hypoxia produced dilation of magnitude quite similar to that observed during a 10-min exposure period, the dilation seen during 20 and 40 min was decreased from that observed during either a 5-or 10-min hypoxic exposure (Fig. 1) .
Contribution of opioids to hypoxic pial artery dilation as a function of stimulus duration. Moderate and severe hypoxia had no effect on cortical periarachnoid CSF methionine enkephalin or dynorphin concentration during a 5-min stimulus period (Fig. 2) . During a 10-min stimulation, however, both opioids were in- 
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OPIOIDS AND HYPOXIC STIMULUS DURATION creased in CSF. During 20-and 40-min exposure periods, the CSF concentration of dynorphin also was increased, whereas that of methionine enkephalin decreased (Fig 2) . The µ-opioid (methionine enkephalin) antagonist ␤-funaltrexamine (10 Ϫ8 M) had no influence on dilation during the 5-min exposure, decremented the 10-and 20-min exposure, but had no effect on 40-min exposure hypoxic dilation (Fig. 3) . Whereas the -opioid (dynorphin) antagonist norbinaltorphimine (10 Ϫ6 M) similarly had no effect on a 5-min exposure dilation, it, in contrast, potentiated 10-, 20-, and 40-min exposure dilations, respectively (Fig. 4) . In fact, norbinaltorphimine substantially restored dilation during the 40-min exposure back toward the response observed during a 10-min exposure ( Figs. 1 and 4) . ␤-Funaltrexamine had no effect by itself on pial artery diameter (140 Ϯ 5 vs. 139 Ϯ 6 µm, n ϭ 5). Norbinaltorphimine similarly had no effect on pial diameter.
Blood chemistry and mean arterial blood pressure. Blood chemistry and mean arterial blood pressure values were obtained at the beginning and end of all experiments as well as during hypoxia. Hypoxia decreased Pa O 2 as expected, whereas the pH, Pa CO 2 , and mean arterial blood pressure values were unchanged (Tables 3 and 4 ).
DISCUSSION
Results of the present study show that whereas 5 min of hypoxia produced pial artery dilation of magnitude quite similar to that observed during a 10-min exposure period, the dilation seen during 20 min was 
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OPIOIDS AND HYPOXIC STIMULUS DURATION somewhat decreased and that to 40 min substantially decreased from that observed during either a 5-or 10-min hypoxic exposure. These results indicate that the duration of the stimulus determines the nature of the vascular response to hypoxia. As such, these results are novel and were unanticipated from the original experimental design. However, it should be noted that, when administered to a whole animal, a step change in the inspired concentration of oxygen will often require 10-15 min to produce a stable Pa O 2 due to the many systemic circulatory adjustments hypoxia induces. Thus the measurements at 5 or 10 min of hypoxia may not be steady-state responses, whereas those at 20 and 40 min may have been. This difference in stimulus dynamics could complicate data interpretation.
Additional studies were designed to characterize the contribution of opioids to hypoxic pial artery dilation as a function of stimulus duration. These results show that moderate and severe hypoxia had no effect on cortical periarachnoid CSF methionine enkephalin or dynorphin concentration during a 5-min stimulus period. Concomitantly, the µ-opioid (methionine enkephalin) antagonist ␤-funaltrexamine (20) and the -opioid (dynorphin) antagonist norbinaltorphimine (14) had no effect on pial dilation during a 5-min hypoxic stimulus. Taken together, the biochemical data support and corroborate the pharmacological data and indicate that these two opioids do not modulate hypoxic pial dilation when the stimulus period is 5 min in duration. Previously, it had been observed that the synthetic µ-agonist [D-Ala 2 ,N-Me-Phe 4 ,Gly 5 -ol]enkephalin and methionine enkephalin elicited pial dilation that was blocked by ␤-funaltrexamine (10 Ϫ8 M) but unchanged by 7-benzylidenenaltrexone, naltrindole, and norbinaltorphimine, i.e., by µ-, ␦ 1 -, ␦ 2 -, and -opioid receptor antagonists, respectively (1, 2, 14, 17, 18) . Similar cross-selectively pharmacological experiments show that dynorphin pial dilation was blocked by norbinaltorphimine (10 Ϫ6 M) but unchanged by the other opioid antagonists (1, 2) . Neither ␤-funaltrexamine nor norbinaltorphimine, however, had any effect on pial artery diameter by themselves (1) . These data indicate that these agents, at the doses used in this study, are selective probes for characterizing the contributions of µ-or -opioid receptors to a physiological response. Additionally, these data suggest that there is little contribution of these two opioids to baseline pial artery diameter.
In contrast, during a 10-min hypoxic stimulation, both methionine enkephalin and dynorphin CSF concentrations were increased, consistent with previous observations (1) . Additionally, ␤-funaltrexamine attenuated, whereas norbinaltorphimine potentiated, hypoxic pial artery dilation. These data indicate that µ-opioid receptors contribute to, whereas -opioid receptors oppose, hypoxic pial dilation, similarly to previous observations (1) . Taken together, these data also indicate that the role of opioids in hypoxic pial artery dilation is stimulus duration dependent.
Two additional hypoxic exposure periods were also investigated to determine if the nature of the modulation of hypoxic pial dilation by opioids changed with longer stimulation periods. These data show that during 20-and 40-min exposure periods, the CSF concentration of dynorphin continued to increase, whereas that of methionine enkephalin steadily decreased. ␤-Fu- 
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OPIOIDS AND HYPOXIC STIMULUS DURATION naltrexamine attenuated pial artery dilation during a 20-min hypoxic period but had no effect on the 40-min exposure hypoxic pial dilation. On the other hand, norbinaltorphimine potentiated the dilation observed during both 20-and 40-min hypoxic stimulation periods. These data indicate that µ-opioid receptor activation contributes to hypoxic pial dilation during a 20-but not a 40-min stimulation period. In contrast, -opioid modulation of the vascular response became increasingly more important with the longer duration of the stimulus. Such observations may, in fact, serve as a partial explanation for the unanticipated results showing that the duration of the stimulus determines the nature of the vascular response to hypoxia. For example, pharmacological data support and corroborate the biochemical data in this study and suggest that decremented hypoxic pial dilation during longer exposure periods results, at least in part, from decreased release of methionine enkephalin and accentuated release of dynorphin. Additionally, dynorphin is a tone-dependent agent (dilator during resting tone conditions; constrictor when cerebrovascular tone decreased) (4). Because hypoxia increases pial artery diameter, cerebrovascular tone will decrease during this stimulus. Therefore, it is speculated that reversal of dynorphin from a dilator to a constrictor during hypoxia could contribute to decremented dilation during longer stimulation periods, an effect that would only be accentuated because of elevated CSF dynorphin concentration during such periods.
The choice of 10 min as the duration of hypoxia in previous studies was arbitrary. Clinically, episodes of acute hypoxia are variable in duration and often last longer than 10 min. Recent data from Leffler et al. (7) in the newborn pig show that NO and activation of ATP-dependent K ϩ channels do not contribute to pial artery dilation during 5 min of hypoxia. Because previous data from this laboratory show that NO and activation of such K ϩ channels contribute to pial artery dilation during 10 min of hypoxia in the piglet (1, 16, 22) , these studies, together, suggest that the relative importance of other mechanisms involved in hypoxic pial dilation change as a function of the duration of the stimulus.
Potential sources of opioids in cortical periarachnoid CSF are neurons, glia, vascular smooth muscle, and endothelial cells. However, the source of these substances cannot be determined from the present experimental design. Whereas the exact mechanism for coupling of hypoxia to opioid release is uncertain, recent evidence supports roles for NO, cGMP, cAMP, and pituitary adenylate cyclase-activating polypeptide (22, 23) . Additionally, whereas two different sizes of pial arteries were investigated to determine if segmental differences with respect to opioid modulation of hypoxic dilation could be observed, no such difference was readily apparent.
In conclusion, data from the present study show that opioids do not modulate hypoxic pial artery dilation during short but do so during longer exposure periods.
Moreover, hypoxic pial dilation is diminished during longer exposure periods. Decremented hypoxic pial dilation during longer exposure periods results, at least in part, from decreased release of methionine enkephalin and accentuated release of dynorphin. These data suggest that the relative role of opioids in hypoxic pial dilation changes with the stimulus duration.
